Fukuzyu Pharmaceutical Co., Ltd.
FDA inspection history in Toyama, Japan, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Toyama, Japan.
Cited most
Across all Fukuzyu Pharmaceutical Co. observations on file
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.192Production record review1
- 21 CFR 211.194Laboratory records1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.67Equipment cleaning and maintenance1
The complete Fukuzyu Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Toyama, Japan
One Form 483 · 2024 · 4 observations
Latest: Form 483, Jan 19, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-01-19 | 483 Form 483 | Toyama, Japan | 4 | $99 |
Investigators on these documents
FEI number 3002807025 · most recent document Jan 19, 2024
About Fukuzyu Pharmaceutical Co., Ltd.
How many FDA Form 483s has Fukuzyu Pharmaceutical Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Fukuzyu Pharmaceutical Co., Ltd.; the most recent is dated Jan 19, 2024.
When was Fukuzyu Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Fukuzyu Pharmaceutical Co., Ltd. is a Form 483 dated Jan 19, 2024, for the site in Toyama, Japan.
What did FDA cite at Fukuzyu Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Fukuzyu Pharmaceutical Co., Ltd. are 21 CFR 211.165 (Testing and release for distribution), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.194 (Laboratory records), 1 time.